Drug Trial Radar · NCT00489255
Safety/Efficacy of Tigan® to Control Nausea/Vomiting Experienced During Apokyn® Initiation and Treatment
Last checked: Nov 19, 2026Latest source record: Jan 30, 2019 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
117
Actual
Start
May 2007
Primary completion
Dec 2011
Study completion Mar 2012
Sponsor
- Lead sponsor
- IpsenIndustry
- Sponsor type
- Industry
- Collaborators
- INC Research Limited
- First posted
- Jun 21, 2007
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purposes of the study are to determine: i. To assess the efficacy of Tigan® (trimethobenzamide) in preventing nausea and vomiting when initiating therapy with Apokyn® (apomorphine) ii. To determine the optimal duration for continuation of Tigan® following initiation of Apokyn® therapy iii. To assess the safety of Tigan® in combination with Apokyn® iv. To characterize the pharmacokinetic (PK) profile of apomorphine in subjects treated concomitantly with and without Tigan®
Conditions
- Parkinson's Disease
Interventions
Tigan®Drug
Oral capsule, 300mg three times daily
PlaceboDrug
Oral capsule, three times daily
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence of Nausea and/or Vomiting During the Initial Titration of Apokyn® at the Visit on Day 1Time frame: Day 1 (Period 1, Visit 2)
Locations
27 sites in 1 country. Site status is shown where the registry gives one.
Barrow Neurological Movement Disorder Clinic
Phoenix, Arizona
Mayo Clinic
Scottsdale, Arizona
Coastal Neurological Medical Group Inc.
La Jolla, California
Neurosearch, Inc.
Reseda, California
Neurosearch II, Inc.
Ventura, California
Parkinson's Disease and Movement Disorders Center of Boca Raton
Boca Raton, Florida
Neurology at Shands Medical Center
Gainesville, Florida
University of Florida at Jacksonville
Jacksonville, Florida
Neurology Associates of Ormond Beach
Ormond Beach, Florida
Charlotte Neurological Services
Port Charlotte, Florida
Suncoast Neuroscience Associates, Inc.
St. Petersburg, Florida
USF Parkinson's Disease and Movement Disorders Center of Excellence
Tampa, Florida
Emory University
Atlanta, Georgia
NorthShore University Health System
Glenview, Illinois
Iowa Health Physicians
Des Moines, Iowa
Parkinson's & Movements Disorders Center of Maryland
Elkridge, Maryland
Quest Research Institute
Bingham Farms, Michigan
Henry Ford Health System - Franklin Point
Southfield, Michigan
Parkinson's Disease and Movement Disorders Center of Long Island
Commack, New York
Kingston Neurological Associates
Kingston, New York
Raleigh Neurology Associates
Raleigh, North Carolina
Neurological Institute, Cleveland Clinic
Cleveland, Ohio
Neurology Specialist of Dallas P.A
Dallas, Texas
Parkinson's Disease and Movement Disorders Center, Baylor College of Medicine
Houston, Texas
Neurology Associates, P.A.
San Antonio, Texas
East Texas Medical Center
Tyler, Texas
Sentara Neurological Associates
Virginia Beach, Virginia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.